Dietary flavonoids, CYP1A1 genetic variants, and the risk of colorectal cancer in a Korean population

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Cho, Young Ae ^a   Lee, Jeonghee ^a   Oh, Jae Hwan ^a   Chang, Hee Jin ^a   Sohn, Dae Kyung ^a   Shin, Aesun ^a,b   Kim, Jeongseon ^a  

^a National Cancer Center   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYP1A1 PROTEIN, HUMAN; CYTOCHROME P450 1A1; FLAVONOID;

ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL TUMOR; DIET; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA;

ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP1A1; DIET; FEMALE; FLAVONOIDS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; SURVEYS AND QUESTIONNAIRES;

EID: 85028448782     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-00117-8     Document Type: Article

References (37)

1. Shin, A. et al. Increasing trend of colorectal cancer incidence in Korea, 1999–2009. Cancer Res. Treat. 44, 219–226 (2012).
2. Huxley, R. R. et al. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int. J. Cancer 125, 171–180 (2009).
3. Moon, Y. J., Wang, X. & Morris, M. E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro 20, 187–210 (2006).
4. Hodek, P., Trefil, P. & Stiborova, M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 139, 1–21 (2002).
5. Kyle, J. A., Sharp, L., Little, J., Duthie, G. G. & McNeill, G. Dietary flavonoid intake and colorectal cancer: a case-control study. Br. J. Nutr. 103, 429–436 (2010).
6. Nimptsch, K. et al. Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts. Am. J. Clin. Nutr. 103, 184–191 (2016).
7. Zhu, X. et al. Associations between CYP1A1 rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies. Oncotarget 5, 11–35 (2016).
8. Sivaraman, L. et al. CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res. 54, 3692–3695 (1994).
9. Rossi, M. et al. Flavonoids and colorectal cancer in Italy. Cancer Epidemiol. Biomarkers Prev. 15, 1555–1558 (2006).
10. Theodoratou, E. et al. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 16, 684–693 (2007).
11. Lambert, J. D., Hong, J., Yang, G. Y., Liao, J. & Yang, C. S. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am. J. Clin. Nutr. 81, 284S–291S (2005).
12. Fini, L. et al. Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J. Nutr. 137, 2622–2628 (2007).
13. Bobe, G. et al. Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev. Res. (Phila) 3, 764–775 (2010).
14. Manach, C., Williamson, G., Morand, C., Scalbert, A. & Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81, 230S–242S (2005).
15. Heim, K. E., Tagliaferro, A. R. & Bobilya, D. J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 13, 572–584 (2002).
16. Chatuphonprasert, W. et al. Potent modification of inducible CYP1A1 expression by flavonoids. Biol. Pharm. Bull. 33, 1698–1703 (2010).
17. Hoensch, H. P. & Kirch, W. Potential role of flavonoids in the prevention of intestinal neoplasia: a review of their mode of action and their clinical perspectives. Int. J. Gastrointest. Cancer 35, 187–195 (2005).
18. Williamson, G. & Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 81, 243S–255S (2005).
19. Slattery, M. L. et al. CYP1A1, cigarette smoking, and colon and rectal cancer. Am. J. Epidemiol. 160, 842–852 (2004).
20. Cleary, S. P., Cotterchio, M., Shi, E., Gallinger, S. & Harper, P. Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. Am. J. Epidemiol. 172, 1000–1014 (2010).
21. Landi, M. T. et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4, 242–246 (1994).
22. Auton, A. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
23. Hirvonen, A., Husgafvel-Pursiainen, K., Karjalainen, A., Anttila, S. & Vainio, H. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol. Biomarkers Prev. 1, 485–489 (1992).
24. Iacopetta, B. Are there two sides to colorectal cancer? Int. J. Cancer 101, 403–408 (2002).
25. Arts, I. C. W., Jacobs, D. R., Gross, M., Harnack, L. J. & Folsom, A. R. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women’s Health Study (United States). Cancer Causes Control 13, 373–382 (2002).
26. Honma, N. et al. Estrogen receptor-beta gene polymorphism and colorectal cancer risk: effect modified by body mass index and isoflavone intake. Int. J. Cancer 132, 951–958 (2013).
27. Hwang, C. S. et al. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J. Steroid Biochem. Mol. Biol. 101, 246–253 (2006).
28. Liu, T. T. et al. Effects of long-term tea polyphenols consumption on hepatic microsomal drug-metabolizing enzymes and liver function in Wistar rats. World J. Gastroenterol. 9, 2742–2744 (2003).
29. Ross, J. A. & Kasum, C. M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 22, 19–34 (2002).
30. Jun, S., Shin, S. & Joung, H. Estimation of dietary flavonoid intake and major food sources of Korean adults. Br. J. Nutr. 115, 480–489 (2016).
31. Kim, Y. J., Park, M. Y., Chang, N. & Kwon, O. Intake and major sources of dietary flavonoid in Korean adults: Korean National Health and Nutrition Examination Survey 2010–2012. Asia Pac. J. Clin. Nutr. 24, 456–463 (2015).
32. Zamora-Ros, R. et al. Impact of thearubigins on the estimation of total dietary flavonoids in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur. J. Clin. Nutr. 67, 779–782 (2013).
33. Ahn, Y. et al. Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur. J. Clin. Nutr. 61, 1435–1441 (2007).
34. Yang, Y. K., Kim, J. Y. & Kwon, O. Development of flavonoid database for commonly consumed foods by Koreans. Korean J. Nutr. 45, 283–292 (2012).
35. Woo, H. D. et al. Dietary flavonoids and gastric cancer risk in a Korean population. Nutrients 6, 4961–4973 (2014).
36. Willett, W. C., Howe, G. R. & Kushi, L. H. Adjustment for total energy intake in epidemiologic studies. Am. J. Clin. Nutr. 65, 1220S–1228S, discussion 1229S–1231S (1997).
37. Gauderman, W. J., Morrison, J. M. QUANTO1.1: A computer program for power and sample size calculations for genetic-epidemiology studies (2006). Available at: http://biostats.usc.edu/software. Accessed: October 1, 2016.